Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin
- PMID: 6305265
- PMCID: PMC184715
- DOI: 10.1128/AAC.23.4.626
Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin
Abstract
The in vitro activities of cefmenoxime, cefotetan, and N-formimidoyl thienamycin were compared with those of other antimicrobial agents (metronidazole, clindamycin, cefoxitin, and moxalactam) against anaerobic bacteria. The data obtained indicate that N-formimidoyl thienamycin exhibits excellent activity against anaerobic bacteria; cefotetan and cefmenoxime, though less active, should be of value in treating selected anaerobic infections.
Similar articles
-
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.Antimicrob Agents Chemother. 1981 Feb;19(2):248-52. doi: 10.1128/AAC.19.2.248. Antimicrob Agents Chemother. 1981. PMID: 6214986 Free PMC article.
-
In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.Antimicrob Agents Chemother. 1982 Dec;22(6):1079-81. doi: 10.1128/AAC.22.6.1079. Antimicrob Agents Chemother. 1982. PMID: 6961887 Free PMC article.
-
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.Eur J Clin Microbiol. 1982 Feb;1(1):49-51. doi: 10.1007/BF02014140. Eur J Clin Microbiol. 1982. PMID: 6293811
-
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.Antimicrob Agents Chemother. 1981 Oct;20(4):433-6. doi: 10.1128/AAC.20.4.433. Antimicrob Agents Chemother. 1981. PMID: 6282191 Free PMC article.
-
In vitro and pharmacokinetic properties of the carbapenems.Antimicrob Agents Chemother. 1986 Sep;30(3):343-9. doi: 10.1128/AAC.30.3.343. Antimicrob Agents Chemother. 1986. PMID: 3535659 Free PMC article. Review. No abstract available.
Cited by
-
In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.Antimicrob Agents Chemother. 1985 May;27(5):749-52. doi: 10.1128/AAC.27.5.749. Antimicrob Agents Chemother. 1985. PMID: 4015069 Free PMC article.
-
Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.Antimicrob Agents Chemother. 1984 Nov;26(5):673-7. doi: 10.1128/AAC.26.5.673. Antimicrob Agents Chemother. 1984. PMID: 6595961 Free PMC article.
-
Cefmenoxime therapy of serious bacterial infections.Antimicrob Agents Chemother. 1984 Apr;25(4):510-2. doi: 10.1128/AAC.25.4.510. Antimicrob Agents Chemother. 1984. PMID: 6329082 Free PMC article.
-
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001. Drugs. 1987. PMID: 3552595 Review.
-
In vitro antibacterial effects of cephalosporins.Drugs. 1987;34 Suppl 2:44-63. doi: 10.2165/00003495-198700342-00006. Drugs. 1987. PMID: 3319505 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical